In-person registration is now SOLD OUT. Join us for Advancing the Cardiovascular Care of the Oncology Patient virtually to reconnect with your peers, and the faculty. Advancing the Cardiovascular Care ...

In this special edition "Pulsecheck" series within ACC CardiaCast, the CV Team Section has partnered with the Geriatric Section's Palliative Workgroup to share insights on difficult conversations that ...

JACC: Advances is seeking submissions of high-impact papers for a special issue focused on implementation science and cardiovascular learning health systems (LHS). Submissions can range from pragmatic ...

With your help, ACC Advocacy actively works with Congress, state legislators, and other key decision makers to transform cardiovascular care and improve heart health. However, we need everyone's voice ...

Restricting sodium content in processed foods reduced blood pressure (BP) in one study and using a salt substitute reduced risks of stroke recurrence and death in another study, both published Feb. 5 ...

In this week’s View, Dr. Eagle looks at cardiac rehabilitation for people with heart failure. He then discusses managing cardiovascular (CV) disease in cancer survivors who have completed cancer ...

Cardiovascular care delivered by the Veterans Healthcare Administration (VHA) is equivalent or better than that provided by non-VHA community care, according to a State-of-the-Art Review by the ACC ...

Additional rhythm-control strategies are frequently continued after index ablation for atrial fibrillation (AFib), according to a study published Feb. 12 in JACC: Clinical Electrophysiology. One in ...

In a contemporary population of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) treated with tafamidis, long-term mortality was relatively high, according to a multicenter study published ...

The SGLT2 inhibitor empagliflozin did not lower the risk of a first hospitalization for heart failure (HF) or death from any cause among patients with an increased risk for HF following acute ...